ALACT.PA
Price:
$0.25
Market Cap:
$3.94M
Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Industry
Biotechnology
IPO Date
2021-11-01
Stock Exchange
PAR
Ticker
ALACT.PA
According to Acticor Biotech SAS’s latest financial reports and current stock price. The company's current ROE is 493.38%. This represents a change of -143.44% compared to the average of -1135.66% of the last 4 quarters.
The mean historical ROE of Acticor Biotech SAS over the last ten years is 58.70%. The current 493.38% ROE has changed 740.53% with respect to the historical average. Over the past ten years (40 quarters), ALACT.PA's ROE was at its highest in in the December 2022 quarter at 381.99%. The ROE was at its lowest in in the June 2023 quarter at -5062.89%.
Average
58.70%
Median
-6.58%
Minimum
-445.86%
Maximum
707.89%
Discovering the peaks and valleys of Acticor Biotech SAS ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 697.05%
Maximum Annual ROE = 707.89%
Minimum Annual Increase = -9122.50%
Minimum Annual ROE = -445.86%
| Year | ROE | Change |
|---|---|---|
| 2023 | 350.84% | -50.44% |
| 2022 | 707.89% | -718.62% |
| 2021 | -114.43% | -74.33% |
| 2020 | -445.86% | 697.05% |
| 2019 | -55.94% | -41.74% |
| 2018 | -96.02% | -137.43% |
| 2017 | 256.52% | -9122.50% |
| 2016 | -2.84% | -64.12% |
| 2015 | -7.92% | 51.41% |
| 2014 | -5.23% | -151.95% |
The current ROE of Acticor Biotech SAS (ALACT.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
314.77%
5-year avg
88.50%
10-year avg
58.70%
Acticor Biotech SAS’s ROE is greater than Hybrigenics S.A. (-679.52%), greater than NOXXON Pharma N.V. (-236.45%), greater than Quantum Genomics S.A. (-156.81%), greater than Lysogene S.A. (-1129.83%), less than Deinove S.A. (60.55%), greater than PHAXIAM Therapeutics S.A. (-95.68%), greater than TheraVet S.A. (-23.15%), less than Medesis Pharma S.A. (142.49%), greater than Neovacs S.A. (-179.41%), less than Pharnext S.A. (82.57%),
| Company | ROE | Market cap |
|---|---|---|
| -679.52% | $3.95M | |
| -236.45% | $0 | |
| -156.81% | $5.00M | |
| -1129.83% | $4.95M | |
| 60.55% | $1.13M | |
| -95.68% | $1.01M | |
| -23.15% | $10.02M | |
| 142.49% | $1.80M | |
| -179.41% | $6.58K | |
| 82.57% | $1.19K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acticor Biotech SAS using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acticor Biotech SAS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Acticor Biotech SAS's ROE?
How is the ROE calculated for Acticor Biotech SAS (ALACT.PA)?
What is the highest ROE for Acticor Biotech SAS (ALACT.PA)?
What is the 3-year average ROE for Acticor Biotech SAS (ALACT.PA)?
What is the 5-year average ROE for Acticor Biotech SAS (ALACT.PA)?
How does the current ROE for Acticor Biotech SAS (ALACT.PA) compare to its historical average?